All fluff Ckent! Wheres my undisclosed rare disease, I want it now!! Lol (sarc)
One thing positive is Dr. Missling has been steady as they come, cool as a cucumber slowly layering trial data making his case for approval in multiple diseases…convincingly imo. Some call these “dog n pony” shows but I disagree. He is communicating to the medical community and shareholders at each one that we are still on track. If we werent, where are the lawsuits? Where are all the naysayers in a court of law when he repeats his claims that we met both endpoints in our Ad trial? The fact is there are none and we ARE well our way to approval in AD and Rett Syndrome.
OAN, at what point does all the symptomatic relief of for each indication help get prophylactic approval helping other diseases. Many of the symptoms of Alzheimer’s and PD are associated with general aging just as many of the symptoms of Rett Syndrome cross into many other rare diseases. Perhaps it will take the “second round” of trials planned to get completed showing efficacy to get full approval for prophylactic use because you know, you have to have 2 decades of safety before you can prove its safe. Meanwhile you approve drugs that are killing patients and show marginal to no efficacy whatsoever.
Jmho
News 
Market Data 
Discover 
